Angela Glendenning

Angela Glendenning has over 20 years of work experience in the pharmaceutical industry. Angela is currently working as the Associate Director of Formulation at Perfuse Therapeutics since November 2020. Prior to this, they served as a Sr. Scientist Pre-Formulation and Scientist Drug Delivery at Aerie Pharmaceuticals from 2017 to 2020. At Aerie Pharmaceuticals, they were responsible for managing collaborations with external companies and contract manufacturing organizations, as well as developing in-house capabilities for formulation development.

Earlier in their career, Angela worked at GSK for over 15 years in various roles. As a Process Technologist, they facilitated the transfer of new products into a commercial site. Angela also served as an Investigator/Senior Scientist in Emerging Markets Research & Development, where they developed solid oral dosage forms and authored technical documents for project progression and transfer. In addition, they worked as a Senior Scientist in Exploratory Development Sciences, supporting program progression from pre-candidate selection to human studies. During their time at GSK, Angela also served as a Scientist in Product Development and as an Associate Scientist in Product Line Extensions, where they provided analytical support and developed methods for regulatory submissions.

Throughout their career, Angela Glendenning has demonstrated expertise in formulation development, manufacturing process transfer, and collaboration with external partners. Angela has successfully led cross-functional teams and mentored scientists, contributing to the advancement of various drug development projects.

Angela Glendenning attended the University of North Carolina Wilmington, where they pursued a Bachelor's Degree in Chemistry. Angela also studied Marine Biology at the University of North Carolina at Wilmington, earning another Bachelor's Degree.